Investment
Continued participation in Kasvu Therapeutics' €30M Series A round led by Hadean Ventures for its neuroplasticity-based depression treatment.
Kasvu Therapeutics
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Kasvu Therapeutics
DCR Tech
Taaleri acquires 51% majority stake in NSI
SmartCap invests €3M in NSI
Mart Maasik joins EstVCA board
Mu-Ray Tech